Abstract The structure-activity relationship of 18-carbon fatty acids (C 18 FAs) on human neutrophil functions and their underlying mechanism were investigated. C 18 unsaturated (U)FAs potently inhibited superoxide anion production, elastase release, and Ca 21 mobilization at concentrations of UFAs did not reduce extracellular Ba 21 entry in FMLP-and thapsigargin-activated neutrophils. In summary, the inhibition of neutrophil functions by C 18 UFAs is attributed to the blockade of Ca 21 mobilization through modulation of PMCA. We also suggest that both the free carboxy group and the number of double bonds of the C 18 UFA structure are critical to providing the potent anti-inflammatory properties in human neutrophils.-Hwang,
FAs have been reported to exert their effects by modulating immune cell functions, resulting in stimulation and/or inhibition of the production of cytokines, chemokines, growth factors, reactive oxygen species (ROS), lipid mediators, and antibodies (1) (2) (3) . PUFAs are thought to play an important function in the prevention and treatment of cardiovascular, inflammatory, and autoimmune diseases (4) (5) (6) (7) . Alterations in dietary levels of linear-chain 18-carbon (C 18 ) unsaturated (U)FAs have significant benefits in cardiovascular diseases and inflammatory syndromes (8) (9) (10) (11) (12) . However, not all studies support the anti-inflammatory role of C 18 FAs in neutrophils. Depending on the experimental conditions, C 18 FAs can either inhibit or enhance neutrophil activation. For example, the saturated FA, stearic acid (SA; C 18 :0), and the UFAs, oleic acid (OA; C 18 :1n-9), linoleic acid (LA; C 18 :2n-6), and g-linolenic acid (gLA; C 18 :3n-6), have been shown to elicit ROS generation, CD11b expression, leukotriene B 4 production, and/or b-glucuronidase release (13) (14) (15) (16) (17) . In contrast, some studies reported that OA, LA, and gLA inhibit ROS generation, myeloperoxidase release, and/or phagocytosis in neutrophils (18, 19) . The controversial results of those studies may be due to different concentrations used. For example, OA and LA at high concentrations (100 and 1,000 mM) induced ROS production by themselves, whereas both C 18 UFAs at low concentrations (1-10 mM) inhibited formyl-L-methionyl-L-leucyl-Lphenylalanine (FMLP)-activated ROS release in human neutrophils (20) . OA at high (40 and 80 mM) but not low concentrations (2.5, 5, and 10 mM) elicited CD11b expression in human neutrophils (15) . Obviously, further research is needed to clarify the effects and action mechanisms of C 18 FAs in neutrophil functions.
Neutrophils play a pivotal role in the defense of the human body against infections. However, overwhelming activation of neutrophils is known to elicit tissue damage. Human neutrophils are known to play important roles in the pathogenesis of various diseases, such as ischemic heart disease, acute myocardial infarction, sepsis, and atherogenesis (21) (22) (23) (24) . In response to diverse stimuli, activated neutrophils secrete a series of cytotoxins, such as the superoxide anion (O 2
•2 ), a precursor of other ROS, granule proteases, and bioactive lipids (25, 26) . O 2
•2 production is linked to the killing of invading microorganisms, but it can also directly or indirectly cause damage by destroying surrounding tissues. Neutrophil granules contain many antimicrobial and potentially cytotoxic substances. Neutrophil elastase is a major secreted product of stimulated neutrophils and a major contributor to the destruction of tissue in chronic inflammatory disease (27) . Therefore, it is crucial to restrain respiratory burst and degranulation in physiological conditions while potentiating these functions in infected tissues and organs.
In this study, the effects of a series of linear-chain C 18 FAs on respiratory burst and degranulation were studied in human neutrophils. We found that C 18 UFAs significantly inhibited the generation of O 2
•2 and release of elastase at concentrations of ,10 mM in FMLP-activated human neutrophils. However, C 18 ] i signal responses to G-protein-coupled chemoattractants are obviously important. Herein, we also discuss possible mechanisms of C 18 UFAs that can account for their modulation of [Ca 21 ] i in human neutrophils.
MATERIALS AND METHODS

Materials
C 18 FAs (obtained from Sigma-Aldrich, St. Louis, MO) were dissolved in absolute ethanol and stored under a nitrogen atmosphere at 220°C before use. The final concentration of ethanol in the cell experiments did not exceed 0.1% and did not affect the parameters measured. HBSS was purchased from Gibco BRL (Grand Island, NY). A23187, aprotinin, H89 (N-(2-((p -bromocinnamyl)amino) ethyl)-5-isoquinolinesulfonamide), leupeptin, PMSF, and Ro318220 (3-(1-(3-(amidinothio)propyl-1H-indol-3-yl))-3-(1-methyl-1H-indol-3-yl)maleimide) were obtained from Calbiochem (La Jolla, CA). Fluo 3-AM and fura 2-AM were purchased from Molecular Probes (Eugene, OR). All other chemicals were obtained from Sigma-Aldrich.
Preparation of human neutrophils
Blood was taken from healthy human donors (20-32 years old) by venipuncture, using a protocol approved by the Institutional Review Board at Chang Gung Memorial Hospital. Neutrophils were isolated with a standard method of dextran sedimentation prior to centrifugation in a Ficoll Hypaque gradient and the hypotonic lysis of erythrocytes. Purified neutrophils that contained .98% viable cells, as determined by the trypan blue exclusion method, were resuspended in Ca 21 -free HBSS buffer at pH 7.4 and maintained at 4°C before use.
Measurement of O 2
•2 generation
The O 2 •2 generation assay was based on the superoxide dismutase (SOD)-inhibitable reduction of ferricytochrome c. In brief, after supplementation with 0.5 mg/ml ferricytochrome c and 1 mM Ca 21 , neutrophils (6 3 10 5 /ml) were equilibrated at 37°C for 2 min and incubated with FAs for 5 min. Cells were activated with 100 nM FMLP, 0.5 mM thapsigargin, or 100 nM phorbol myristate acetate (PMA) for 10 min. When FMLP and thapsigargin was used as a stimulant, 1 mg/ml cytochalasin B (CB) was incubated for 3 min before activation. Changes in absorbance with the reduction of ferricytochrome c at 550 nm were continually monitored in a double-beam, six-cell positioner spectrophotometer with constant stirring (Hitachi U-3010; Tokyo, Japan). Calculations were based on differences in the reactions with and without SOD (100 U/ml) divided by the extinction coefficient for the reduction of ferricytochrome c (y 5 21.1/mM/10 mm).
The O 2 •2 -scavenging ability of FAs was determined using xanthine/xanthine oxidase in a cell-free system, based on a previously described method (29) . After 0.1 mM xanthine was added to the assay buffer (50 mM Tris, pH 7.4, 0.3 mM WST-1, and 0.02 U/ml xanthine oxidase) for 15 min at 30°C, the absorbance associated with the O 2
•2 -induced WST-1 reduction was measured at 450 nm.
Measurement of elastase release
Degranulation of azurophilic granules was determined by elastase release. Experiments were performed using MeO-Suc-AlaAla-Pro-Val-p -nitroanilide as the elastase substrate. Briefly, after supplementation with MeO-Suc-Ala-Ala-Pro-Val-p-nitroanilide (100 mM), neutrophils (6 3 10 5 /ml) were equilibrated at 37°C for 2 min and incubated with FAs for 5 min. Cells were activated by FMLP (100 nM) in the presence of CB (0.5 mg/ml), and changes in absorbance at 405 nm were continuously monitored to determine elastase release. The results are expressed as a percentage of the initial rate of elastase release in the FMLP/CB-activated, drug-free control system.
To assay whether FAs exhibit an inhibitory ability toward elastase activity, a direct elastase activity assay was performed in a cellfree system. Neutrophils (6 3 10 5 /ml) were incubated for 20 min in the presence of FMLP (100 nM)/CB (2.5 mg/ml) at 37°C. Cells were then centrifuged at 1,000 g for 5 min at 4°C to collect the elastase from the supernatant. The supernatant was equilibrated at 37°C for 2 min and incubated with or without FAs for 5 min. After incubation, the elastase substrate, MeO-Suc-Ala-Ala-Pro-Valp -nitroanilide (100 mM), was added to the reaction mixtures. Changes in absorbance at 405 nm were continuously monitored for 10 min to assay the elastase activity.
Lactate dehydrogenase release
Lactate dehydrogenase (LDH) release was determined by a commercially available method (Promega, Madison, WI). Neutrophils (6 3 10 5 /ml) were equilibrated at 37°C for 2 min and incubated with FAs for 15 min. Cytotoxicity was represented by LDH release in a cell-free medium as a percentage of the total LDH released. The total LDH released was determined by lysing cells with 0.1% Triton X-100 for 30 min at 37°C.
Determination of cAMP concentration
The cAMP level was assayed using an enzyme immunoassay kit (Amersham Pharmacia Biotech, Buckinghamshire, UK). The reaction of neutrophils was terminated by adding 0.5% dodecytrimethylammonium bromide. Samples were then centrifuged at 3,000 g for 5 min at 4°C. The supernatants were used as a source for the cAMP samples. The assay was performed according to the manufacturerʼs instructions.
Assay of phosphodiesterase activity
Neutrophils (5 3 10 7 cells/ml) were sonicated in ice-cold buffer containing 25 mM Tris-HCl (pH 7.5), 0.25 M sucrose, 2 mM EDTA, 5 mM MgCl 2 , 10 mM leupeptin, 100 mM PMSF, and 10 mM pepstatin. Unbroken cells were removed by centrifugation at 300 g for 5 min, and then the supernatant was centrifuged at 100,000 g for 40 min at 4°C. The cytosolic fraction was used as the source for the phosphodiesterase (PDE) enzymes. PDE activity was analyzed using a tritium scintillation proximity assay system, and the assay was performed according to the manufacturerʼs instructions (Amersham Pharmacia Biotech). Briefly, assays were performed at 30°C for 10 min in the presence of 50 mM Tris HCl (pH 7.5) containing 8.3 mM MgCl 2 , 1.7 mM EGTA, and 0.3 mg/ml BSA. Each assay was performed in a 100-ml reaction volume containing the above buffer, the neutrophil supernatant fraction, and around 0.05 mCi [ 3 H]cAMP. The reaction was terminated by the addition of 50 ml PDE scintillation proximity assay beads (1 mg) suspended in 18 mM zinc sulfate. Assays were performed in 96-well microtiter plates. The reaction mixture was allowed to settle for 1 h before counting in a microtiter plate counter.
Measurement of [Ca
] i
Neutrophils were loaded with 2 mM fluo 3-AM at 37°C for 45 min. After being washed, cells were resuspended in Ca 21 -free HBSS to 3 3 10 6 cells/ml. In some experiments, neutrophils were suspended in sodium (Na 1 )-deprived HEPES buffer (124 mM N-methyl-D-glucamine, 4 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 0.64 mM K 2 HPO 4 , 0.66 mM KH 2 PO 4 , 5.56 mM dextrose, 10 mM HEPES, and 15.2 mM KHCO 3 , pH 7.4) (30). The change in fluorescence was monitored using a Hitachi F-4500 spectrofluorometer (Tokyo, Japan) in a quartz cuvette with a thermostat (37°C) and continuous stirring. The excitation wavelength was 488 nm, and the emission wavelength was 520 nm. FMLP, thapsigargin, and A23187 were used to increase [Ca 21 
, where F is the observed fluorescence intensity, F max and F min were respectively obtained by the addition of 0.05% Triton X-100 and 20 mM EGTA, and K d was taken to be 400 nM.
Measurement of barium influx
Neutrophils were loaded with 4 mM fura 2-AM at 37°C for 45 min. After being washed, cells were resuspended in Ca 21 -free HBSS to 3 3 10 6 cells/ml. The entry of barium (Ba 21 ) into FMLPand thapsigargin-stimulated neutrophils was measured, followed by the addition of 1 mM Ba 21 to Ca 21 -free medium. Ba 21 uptake was monitored from the increase in fura 2 fluorescence at 510 nm with excitation at 360 nm, which is insensitive to variations in [Ca 21 ] i (31) .
Assay of plasma membrane Ca 21 -ATPase activity
Neutrophils were sonicated in ice-cold Tris buffer (pH 7.4), and then cells were centrifuged at 20,000 g for 40 min at 4°C. The pellet fraction was collected and used as the source of Ca 21 -ATPase enzymes. Ca 21 -ATPase activity was measured using an assay in which ATP hydrolysis is coupled to NADH oxidation by pyruvate kinase with phosphoenolpyruvate and LDH (32, 33) . ATP hydrolysis was measured in 800 ml of relaxation buffer containing 8 3 10 6 cell equivalents of membrane extract, 20 mM HEPES (pH 7.4), 130 mM NaCl, 4 mM MgCl 2 , 3 mM ATP, 0.2 mM CaCl 2 , 0.8 mM NADH, 1.68 mM phosphoenolpyruvate, 24 units of pyruvate kinase, 57.6 units of LDH, 10 mM ouabain, and 10 mM thapsigargin at 25°C. Changes in absorbance at 340 nm were continually monitored in a double-beam, six-cell positioner spectrophotometer with constant stirring. After incubation for 5 min, FAs (5 mM) and calmodulin (10 mg/ml) were added to the assay buffer, and the ATPase activity was measured for 50 min. The mmol extinction coefficient for NADH was 6.22. Plasma membrane Ca 21 -ATPase (PMCA) activity was calculated from the slope of the tracing curve between 20 and 35 min and expressed as mmol Pi/1 3 10 7 cells/h.
Statistical analysis
The 50% inhibitory concentration (IC 50 ) values were calculated from concentration response curves obtained from several independent experiments using Sigmaplot (Jandel Scientific, San Rafael, CA). Data are presented as the mean 6 SEM, and comparisons were made using Studentʼs t-test. A probability of ,0.05 was considered significant.
RESULTS
C 18 UFAs inhibit O 2
•2 generation and elastase release in FMLP/CB-induced human neutrophils but not in cell-free systems
To investigate whether C 18 FAs reduced respiratory burst and degranulation by human neutrophils in response to FMLP/CB, the amounts of O 2
•2 and elastase were determined. UFAs significantly inhibited O 2
•2 production and elastase release in FMLP/CB-activated human neutrophils in a concentration-dependent manner with IC 50 values of ,10 mM ( Table 1, Fig. 1A ). The inhibitory potencies of C 18 UFAs were in the order of cis-vaccenic acid (CVA; C 18 :1n-7) . OA . LA . a-linolenic acid (aLA; C 18 :3n-3) 5 gLA . stearidonic acid (C 18 :4n-3), indicating that the inhibitory actions decreased in the following order: C 18 :1 . C 18 :2 . C 18 :3 . C 18 :4. Nevertheless, the comparison of data shows that there are no preferences for the double bound position of C 18 UFAs on the anti-inflammatory activity. In addition, neither OA methyl ester (OA-me) nor LA-me inhibited these neutrophil functions. The saturated SA (C 18 :0) at a concentration of 10 mM showed minor effects in human neutrophils. On the other hand, none of these C 18 FAs altered the basal O 2
•2 generation or elastase release under resting conditions. Moreover, none of these C 18 FAs (up to 30 mM) scavenged O 2
•2 formation or inhibited elastase activity in cell-free systems (data not shown). These data rule out the possibility that the inhibitory effects of C 18 UFAs on O 2
•2 release occur through scavenging of O 2
•2 and elastase. Culturing with C 18 FAs (up to 10 mM) did not affect cell viability, as assayed by LDH release (data not shown). Moreover, O 2
•2 release induced by PMA (100 nM), a protein kinase C (PKC) activator, was not inhibited by OA, CVA, and LA (5 mM) (Fig. 1C) , suggesting that C 18 UFAs exert their inhibitory influence by interfering with specific cellular signaling pathways.
The effect of C 18 UFAs on O 2
•2 generation and elastase release in human neutrophil in the presence of BSA was also investigated to determine whether these FAs could inhibit human neutrophil functions under more physiological condition. As shown in Fig. 1B , FMLP/CB-induced O 2
•2 generation and elastase release were inhibited by higher concentrations (1-10 mM) of OA and CVA in the presence of 0.1% BSA. In addition, OA-me even at higher concentrations (1-10 mM) did not alter FMLP/CBinduced O 2
•2 generation and elastase release in the presence of 0.1% BSA (data not shown). These results indicate that C 18 ] i caused by the subsequent addition of 1 mM Ca 21 were inhibited by C 18 UFAs ( Table 2 , Fig. 2B ). The latter responses were also confirmed when OA, CVA, and LA were added before or after the reintroduction of Ca 21 ( Fig. 2C) . On the other hand, OA, CVA, and LA (5 mM) significantly inhibited O 2
•2 production in FMLP/CB-activated human neutrophils in Ca 21 -free medium (Fig. 2D) ] i changes in thapsigarginactivated human neutrophils (Fig. 3A) . In line with these data, thapsigargin/CB-induced O 2
•2 generation was moderately reduced by OA, CVA, and LA (5 mM) (Fig. 1D) (Fig. 3B, C) .
The cAMP pathway is not involved in the inhibitory effects of C 18 UFAs Elevation of intracellular cAMP concentrations has been demonstrated to inhibit the generation of O 2
•2 and the release of elastase, as well as to shorten the value of t 1/2 in FMLP-activated human neutrophils (36, 37) . To examine whether cAMP pathways are involved in the inhibitory effects of C 18 UFAs, cAMP concentrations and PDE activities were assayed. PGE 1 (an adenylate cyclase activator) and rolipram (a PDE4 inhibitor) were used as positive controls. Neither cAMP concentrations nor cAMP PDE activities were altered by OA, CVA, or LA (Fig. 4A, B) . Moreover, the protein kinase (PK)A inhibitor, H89, did not restore the UFA-induced inhibition of O 2
•2 release (Fig. 4C) . (38, 39) . It has been reported that PKC is able to inhibit SOCE in human neutrophils (31) . In agreement with this finding, low concentrations of PMA (1 and 3 nM) concentration-dependently inhibited extracellular Ca 21 entry in FMLP-activated human neutrophils, which was completely abolished by the PKC inhibitor, Ro318220 For all data, values are the mean 6 SEM (n 5 3-7). *P , 0.05, ** P , 0.01, and *** P , 0.001 compared with the control. SDA, stearidonic acid; OA-me, OA-methyl ester; LA-me, LA-methyl ester. •2 generation and elastase release were induced by FMLP/CB and respectively measured using SOD-inhibitable cytochrome c reduction and by monitoring p-nitroanilide release, as described in Materials and Methods. All data are expressed as the mean 6 SEM (n 5 3-7). * P , 0.05, ** P , 0.01, and *** P , 0.001 compared with the control. •2 generation was measured using SOD-inhibitable cytochrome c reduction. All data are expressed as the mean 6 SEM (n 5 3). ** P , 0.01 and *** P , 0.001 compared with the control. (Fig. 5A) . In contrast, Ro318220 failed to alter either CVA-or LA-produced inhibition of extracellular Ca 21 entry (Fig. 5B) . (Fig. 6) . These data suggest Ba 21 entry via SOCE in FMLP-and thapsigargin-activated human neutrophils. In contrast, OA, CVA, and LA (5 mM) failed to alter the 21 . For all data, values are the mean 6 SEM (n 5 4-5). *P , 0.05, ** P , 0.01, and *** P , 0.001 compared with the control.
entry of Ba 21 in FMLP-and thapsigargin-activated human neutrophils (Fig. 6 ).
Effects of Na 1 deprivation on the inhibition of C 18 UFAs
The existence of a Na 1 -Ca 21 exchange mechanism on the plasma membrane of neutrophils was previously described (40) . It is known that the plasma membrane Na 1 -Ca 21 exchanger (NCX) plays a role in removing Ca 21 from the cytosol. To examine whether the NCX is involved in the inhibitory effects of C 18 UFAs, experiments were carried out in Na 1 -free solutions to avoid a possible contribution of the NCX. As shown in Fig. 7 , OA, CVA, and LA (5 mM) significantly inhibited O 2
•2 production and shortened the value of t 1/2 in FMLP-activated human neutrophils in Ca 21 -containing Na 1 -deprived medium, suggesting that the role of the NCX can be excluded.
Effects of C 18 FAs on PMCA activity
Calcium homeostasis is maintained through a balance between cell membrane permeability and the energydependent transport of Ca 21 by Ca 21 -ATPase at the level of the cell membrane and at the level of ER. To address the effects of C 18 UFAs on PMCA pumps, PMCA activity was assayed in human neutrophils as previously described (30) with some modifications. Neutrophils were preincubated with thapsigargin (0.5 mM) and A23187 (0. ] i in this assay (Fig. 8A) . The effects of C 18 FAs on PMCA activities were further tested by determining ATPase activities in neutrophil membrane fractions in the presence of thapsigargin and ouabain to inhibit ERCA and Na 1 /K 1 ATPase. The removal of Ca 21 from the cytosol is maintained through an energydependent process. Since no ATP hydrolysis was observed when the plasma membrane was subtracted, the results suggest that the difference in the rate of ATP hydrolysis in the presence or absence of C 18 FAs results through modulation of ATPase activity in the plasma membrane. As shown in Fig. 8B , the activities of PMCA were significantly enhanced by C 18 mono-and bi-UFAs and by calmodulin. OA, CVA, LA, and calmodulin enhanced the activities of ATPase from 0.39 6 0.03 (control) to 0.65 6 0.02 (P , 0.001), 0.62 6 0.06 (P , 0.01), 0.58 6 0.05 (P , 0.01), and 0.58 6 0.02 mmol Pi/1 3 10 7 cells/h (P , 0.001), respectively. In contrast, the C 18 saturated FA and esterified UFAs had no effect on PMCA activities (Fig. 8B) .
DISCUSSION
In this study, a cellular model of isolated human neutrophils was established to elucidate the anti-inflammatory functions of linear-chain C 18 FAs. Our data show that C 18 UFAs potently inhibited the generation of O 2
•2 and the release of elastase in FMLP-activated human neutrophils Fig. 4 . Effect of C 18 UFAs on the cAMP pathway in human neutrophils. A: Neutrophils were incubated with ethanol (0.1%, control), FAs (5 mM), or PGE 1 (1 mM) for 10 min, and cAMP was assayed using an enzyme immunoassay kit. B: Neutrophil homogenates were incubated with ethanol (0.1%, control), FAs (5 mM), or rolipram (3 mM), and then 0.05 mCi [ 3 H] cAMP was added to the reaction mixture at 30°C for 10 min. PDE activity was measured as described in Materials and Methods. C: O 2
•2 generation was induced by FMLP/CB and measured using SOD-inhibitable cytochrome c reduction. H89 (3 mM) was preincubated for 5 min before the addition of ethanol, FAs, and PGE 1 . Data are shown as the mean 6 SEM (n 5 3-4). ***P , 0.001 compared with the control. in a concentration-dependent fashion with IC 50 values of ,10 mM. The inhibitory potency decreased with an increasing number of double bonds in C 18 UFAs. When the carboxy group of C 18 mono-or bi-UFA was chemically modified by adding a methyl ester, however, these C 18 UFAs did not exhibit inhibition. In addition, the C 18 saturated FA caused no effect on human neutrophil responses. Multiple observations made in the study suggest that C 18 UFAs suppress respiratory burst and degranulation of human neutrophils through an increase in the clearance of cytosolic Ca 21 . It is well established that Ca 21 signaling is a key second messenger regulating neutrophil functions (34) . Consistent with this, BAPTA-AM, a cell-permeable Ca 21 chelator, inhibited the generation of O 2
•2 and the release of elastase in FMLP-activated human neutrophils (data not shown). Interestingly, C 18 •2 generation was reduced by OA, CVA, and LA.
Calcium homeostasis is maintained through a complex set of mechanisms that controls cellular Ca 21 influx and efflux as well as intracellular Ca 21 stores. Because of this critical dependence of activation of the proinflammatory activities of neutrophils on Ca 21 , the mechanisms used by these cells to both mobilize and dispose of Ca 21 have been identified as potential targets for anti-inflammatory agents (34) . We previously reported that cAMP-elevating agents can accelerate Ca 21 clearance from the cytosol as well as inhibit the generation of O 2
•2 and the release of elastase in FMLP-activated human neutrophils (36, 37) . This contention is supported by a previous study, which reported that cAMP/protein kinase A increases the Ca 21 sequestering/ resequestering activity of ERCA by phosphorylation of the regulatory polypeptide, phospholamban (41) . In this study, however, we show that pretreatment with a protein kinase A inhibitor did not restore the UFA-induced inhibition of O 2
•2 release, suggesting that a cAMP-dependent pathway is not involved in the inhibition of C 18 UFAs. Consistent with this result, C 18 mono-, bi-, and tri-UFAs failed to elevate the concentrations of cAMP or to alter the activities of cAMP-specific PDEs.
Murakami, Chan, and Routtenberg (42) Our data confirmed that PMA concentration-dependently inhibited extracellular Ca 21 and Ba 21 entry in FMLP-and thapsigargin-activated human neutrophils, which was completely abolished by Ro318220, a PKC inhibitor. Nevertheless, a role for PKC in C 18 UFA-mediated inhibition was ruled out because the C 18 (45) . Moreover, PMCA activity is also influenced by the membrane lipid composition and structure (33). Adamo et al. (46) suggested that acidic phospholipids activate PMCA by interacting with an independent acidic lipid-responsive region. This study showed that the activities of PMCA were significantly enhanced by C 18 mono-and bi-UFAs activated human neutrophils and in isolated neutrophil membranes. Consistent with these results, it was reported that purified PMCA of erythrocyte membranes can be activated by the C 18 UFAs, OA and LA (47) . Our results show that the increasing potency of C 18 FAs on PMCA activities appears to be correlated with decreases in O 2
•2 generation and elastase release as well as the accelerated clearance of [Ca 21 ] i in human neutrophils. Similarly, Oda et al. (48) reported that both the free carboxy group and the number of double bonds of the C 18 UFA structure are important in providing a potent telomerase-inhibitory effect. The three-dimensional structure of the telomerase active site appears to have a pocket that could bind OA (48) . It is obvious that an analysis of the binding sites of C 18 UFAs on PMCA and telomerase will be critical in clarifying the molecular mechanism of C 18 UFAs.
Although the effect of C 18 FAs on human neutrophil functions has been studied extensively, several points remain to be fully established, as some authors have found an increase (13) (14) (15) (16) (17) , whereas others have found a decrease (18, 19) , in ROS generation, CD11b expression, leukotriene B 4 production, enzyme release, and/or phagocytosis by neutrophils in response to C 18 FA treatment. Contradictory observations reported in previous studies may in part be the result of different concentrations and methods used to determined neutrophil functions. For example, OA and LA at high concentrations (100 and 1,000 mM) induced ROS production by themselves, whereas both C 18 UFAs at low concentrations (1-10 mM) inhibited FMLP-activated ROS release in human neutrophils (20) . Furthermore, we found that exposure of human neutrophils to high concentrations (30 and 50 mM) of C 18 FAs caused a concentrationdependent increase in LDH release (data not shown). Additionally, Hatanaka et al. (14) showed that OA, LA, and gLA at high concentrations (50 and 100 mM) per se lead to cytochrome c reduction. Our data indicate that C 18 UFAs significantly suppressed O 2
•2 generation and elastase release in activated human neutrophils in a concentrationdependent manner with IC 50 values of ,10 mM. Activated neutrophils that produce ROS and granule proteases are 18 FAs on PMCA activity in human neutrophils and in isolated neutrophil membranes. A: Fluo 3-loaded neutrophils were stimulated with thapsigargin (TG; 0.5 mM) plus A23187 (0.2 mM), and subsequently EGTA (1 mM) was added in combination with FAs (5 mM) or PMA (3 nM) in Ca 21 -containing Na 1 -deprived medium supplemented with oligomycin A (1 mM) and CCCP (1 mM). B: PMCA activity of neutrophil membranes was measured using a coupled enzyme assay in the presence of ouabain (10 mM) and thapsigargin (10 mM) as described in Materials and Methods. The indicated FAs (5 mM) and calmodulin (10 mg/ml) were added to the assay buffer, and the ATPase activity was measured spectrophotometrically at 340 nm for 50 min at 25°C with stirring. The traces shown are from four or seven different experiments.
involved in oxidative stress and inflammation. Alterations in dietary levels of C 18 UFAs have significant clinical benefits in cardiovascular diseases and inflammatory syndromes (8) (9) (10) (11) (12) . LA, aLA, and gLA are thought to have important functions in preventing and treating coronary artery disease and rheumatoid arthritis (8, 12) . However, Juttner et al. (49) showed that parenteral nutrition containing OA and LA can induce O 2
•2 generation of neutrophils. Obviously, further research is needed to clarify the effects of C 18 UFAs in neutrophil functions before the therapeutic potential of C 18 UFAs in inflammation can be realized.
In conclusion, this study shows that C 18 UFAs inhibit human neutrophil proinflammatory responses, including respiratory burst, degranulation, and Ca 21 mobilization. These anti-neutrophilic inflammatory effects are mediated through the elevation of the PMCA activity. Also, our results suggest that both the free carboxy group and the number of double bonds of the C 18 UFA structure are critical in providing the potent inhibitory effects in human neutrophils.
